论文部分内容阅读
Mepindolol是一种新的β-受体阻断剂。本文报告在7名23～34岁男性正常志愿者中进行的Mepindolol与心得静临床和血流动力学的比较研究结果。
Mepindolol is a new beta-blocker. This article reports the results of a comparative study of Mepindolol with clinically relevant and clinically significant hemodynamics in seven normal volunteers aged 23-34 years.